Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours

This publication has 32 references indexed in Scilit:

• High risk of therapy-related leukemia and preleukemia after therapy with prednimustine, methotrexate, 5-fluorouracil, mitoxantrone, and tamoxifen for advanced breast cancer
  Cancer, 1990
• Risk of Second Cancers after Treatment for Hodgkin's Disease
  New England Journal of Medicine, 1988
• RISK OF THERAPY-RELATED LEUKAEMIA AND PRELEUKAEMIA AFTER HODGKIN'S DISEASE
  The Lancet, 1987
• A comparison of the incidence of the myelodysplastic syndrome and acute myeloid leukaemia following melphalan and cyclophosphamide treatment for myelomatosis
  British Journal of Cancer, 1987
• Decreasing Risk of Leukemia with Prolonged Follow-up after Chemotherapy and Radiotherapy for Hodgkin's Disease
  New England Journal of Medicine, 1987
• Acute nonlymphocytic leukemia, preleukemia, and solid tumors following intensive chemotherapy of small cell carcinoma of the lung
  Blood, 1985
• Risk of Acute Nonlymphocytic Leukemia and Preleukemia in Patients Treated with Cyclophosphamide for Non-Hodgkin's Lymphomas
  Annals of Internal Medicine, 1985
• Increased incidence of acute nonlymphocytic leukemia following therapy in patients with small cell carcinoma of the lung.
  Journal of Clinical Oncology, 1984
• Acute Nonlymphocytic Leukemia after Therapy with Alkylating Agents for Ovarian Cancer
  New England Journal of Medicine, 1982
• Acute non-lymphocytic leukemia in patients with ovarian carcinoma following long-term treatment with treosulfan (=dihydroxybusulfan)
  Cancer, 1980